Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer.

Schramek D, Leibbrandt A, Sigl V, Kenner L, Pospisilik JA, Lee HJ, Hanada R, Joshi PA, Aliprantis A, Glimcher L, Pasparakis M, Khokha R, Ormandy CJ, Widschwendter M, Schett G, Penninger JM.

Nature. 2010 Nov 4;468(7320):98-102. doi: 10.1038/nature09387. Epub 2010 Sep 29.

2.

RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.

Gonzalez-Suarez E, Jacob AP, Jones J, Miller R, Roudier-Meyer MP, Erwert R, Pinkas J, Branstetter D, Dougall WC.

Nature. 2010 Nov 4;468(7320):103-7. doi: 10.1038/nature09495. Epub 2010 Sep 29.

PMID:
20881963
3.

Progestin effects on cell proliferation pathways in the postmenopausal mammary gland.

Wood CE, Branstetter D, Jacob AP, Cline JM, Register TC, Rohrbach K, Huang LY, Borgerink H, Dougall WC.

Breast Cancer Res. 2013;15(4):R62.

4.

[Bone metastasis and RANKL].

Nakashima T.

Clin Calcium. 2014 Aug;24(8):1201-8. doi: CliCa140812011208. Review. Japanese.

PMID:
25065872
6.

Receptor activator for nuclear factor-κB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis.

Boopalan T, Arumugam A, Parada J, Saltzstein E, Lakshmanaswamy R.

Cancer Sci. 2015 Jan;106(1):25-33. doi: 10.1111/cas.12571.

7.

NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.

Xing L, Bushnell TP, Carlson L, Tai Z, Tondravi M, Siebenlist U, Young F, Boyce BF.

J Bone Miner Res. 2002 Jul;17(7):1200-10.

8.

Cell adhesion signaling regulates RANK expression in osteoclast precursors.

Mochizuki A, Takami M, Miyamoto Y, Nakamaki T, Tomoyasu S, Kadono Y, Tanaka S, Inoue T, Kamijo R.

PLoS One. 2012;7(11):e48795. doi: 10.1371/journal.pone.0048795. Epub 2012 Nov 6.

9.

The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.

Shin M, Matsuo K, Tada T, Fukushima H, Furuta H, Ozeki S, Kadowaki T, Yamamoto K, Okamoto M, Jimi E.

Carcinogenesis. 2011 Nov;32(11):1634-40. doi: 10.1093/carcin/bgr198. Epub 2011 Sep 1.

10.

Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis.

Kimachi K, Kajiya H, Nakayama S, Ikebe T, Okabe K.

Naunyn Schmiedebergs Arch Pharmacol. 2011 Mar;383(3):297-308. doi: 10.1007/s00210-010-0596-4. Epub 2011 Jan 12.

PMID:
21225243
11.

RANKL inhibition: a promising novel strategy for breast cancer treatment.

González-Suárez E.

Clin Transl Oncol. 2011 Apr;13(4):222-8. doi: 10.1007/s12094-011-0646-5. Review.

PMID:
21493182
12.

Receptor activator of NF-κB ligand promotes proliferation of a putative mammary stem cell unique to the lactating epithelium.

Thomas E, Lee-Pullen T, Rigby P, Hartmann P, Xu J, Zeps N.

Stem Cells. 2012 Jun;30(6):1255-64. doi: 10.1002/stem.1092.

13.

High hopes for RANKL: will the mouse model live up to its promise?

Tanos T, Brisken C.

Breast Cancer Res. 2011 Jan 28;13(1):302. doi: 10.1186/bcr2805.

14.

Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling.

Tan W, Zhang W, Strasner A, Grivennikov S, Cheng JQ, Hoffman RM, Karin M.

Nature. 2011 Feb 24;470(7335):548-53. doi: 10.1038/nature09707. Epub 2011 Feb 16.

15.

Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.

Yi T, Lee HL, Cha JH, Ko SI, Kim HJ, Shin HI, Woo KM, Ryoo HM, Kim GS, Baek JH.

J Cell Physiol. 2008 Nov;217(2):409-22. doi: 10.1002/jcp.21511.

PMID:
18543257
16.

Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit.

Duheron V, Hess E, Duval M, Decossas M, Castaneda B, Klöpper JE, Amoasii L, Barbaroux JB, Williams IR, Yagita H, Penninger J, Choi Y, Lézot F, Groves R, Paus R, Mueller CG.

Proc Natl Acad Sci U S A. 2011 Mar 29;108(13):5342-7. doi: 10.1073/pnas.1013054108. Epub 2011 Mar 14.

18.

Effect of radiation on the expression of osteoclast marker genes in RAW264.7 cells.

Yang B, Zhou H, Zhang XD, Liu Z, Fan FY, Sun YM.

Mol Med Rep. 2012 Apr;5(4):955-8. doi: 10.3892/mmr.2012.765. Epub 2012 Jan 25.

19.
20.

RANKL/RANK-beyond bones.

Hanada R, Hanada T, Sigl V, Schramek D, Penninger JM.

J Mol Med (Berl). 2011 Jul;89(7):647-56. doi: 10.1007/s00109-011-0749-z. Epub 2011 Mar 29. Review.

PMID:
21445556
Items per page

Supplemental Content

Write to the Help Desk